Are you looking for creative ways to reach and engage your healthcare audience?
Partner with medwireNews and see how our content and tactics can boost your independent educational activities to optimize your goals.
Specialists in medical education and content creation, we provide solutions that grab the attention of healthcare professionals and inform them on key messages in convenient, easily accessible and timely formats.
Our services can help you build trusted relationships with your healthcare professional audience by supporting them in the knowledge they need to stay up to date and ensure the continued learning essential to improving patient care.
- |
- Oncology |
Chemoprevention use after TNBC ‘may be reasonable’
Research indicates that women with triple-negative breast cancer might benefit from low-dose tamoxifen to reduce the risk of recurrent or new primary disease.
- |
- Neurology |
Mixed results for tetramethylpyrazine nitrone treatment in ALS
Tetramethylpyrazine nitrone does not slow overall functional decline in patients with amyotrophic lateral sclerosis, but it may help retain grip strength and is well tolerated, suggest study findings.
- |
- Oncology |
Quantifying high-risk chromosomal aberrations predicts multiple myeloma prognosis
The presence of two or more high-risk chromosomal aberrations in patients with multiple myeloma is associated with an especially poor outcome throughout the disease course, shows research published in the Journal of Clinical Oncology.
- |
- Oncology |
Cancer-related PE death increase shown in the USA
US study findings indicate that the incidence of pulmonary embolism-related death in people with cancer rose significantly between 2011 and 2020 despite an overall reduction in age-adjusted cancer diagnoses and cancer-related deaths over the period.
- |
- Oncology |
- Paediatrics |
Larotrectinib discontinuation possible for some paediatric NTRK fusion-positive tumours
Children who respond to larotrectinib therapy for sarcoma with a neurotrophic tyrosine receptor kinase gene fusion may be able to discontinue treatment, indicates research published in the Journal of Clinical Oncology.
- |
- Oncology |
Urinary DNA methylation test may improve bladder cancer detection
Measuring levels of urinary DNA methylation may offer a novel and noninvasive test for urothelial cancer, study findings suggest.
- Oncology
- Expert Interviews & Discussion
- Diabetes
- Featured Content Creation
- Rheumatology
- Conference Coverage & Reporting
- Rheumatology
- News Services
- Gastroenterology
- Conference Coverage & Reporting
- Neurology
- Expert Interviews & Discussion
Wealth of Knowledge
Journalistic skills backed by scientific expertise for accurate and relevant reporting
Variety of formats
Convenient, accessible and timely multimedia formats that engage and inform
RANGE OF SPECIALTIES
